Literature DB >> 25810041

Within-class differences of the sulfonylureas should be accounted for. Reply to Schrijnders D, Kleefstra N and Landman GWD [letter].

Jonathan C Levy1, Axel Riefflin, Rury R Holman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25810041     DOI： 10.1007/s00125-015-3574-z

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  6 in total

1.  Within-class differences of the sulfonylureas should be accounted for. Reply to Schrijnders D, Kleefstra N and Landman GWD [letter].

Authors:  Jonathan C Levy; Axel Riefflin; Rury R Holman
Journal:  Diabetologia       Date:  2015-03-26       Impact factor: 10.122

Review 2.  Sulfonylurea stimulation of insulin secretion.

Authors:  Peter Proks; Frank Reimann; Nick Green; Fiona Gribble; Frances Ashcroft
Journal:  Diabetes       Date:  2002-12       Impact factor: 9.461

3.  A meta-analysis of the hypoglycaemic risk in randomized controlled trials with sulphonylureas in patients with type 2 diabetes.

Authors:  M Monami; I Dicembrini; L Kundisova; S Zannoni; B Nreu; E Mannucci
Journal:  Diabetes Obes Metab       Date:  2014-04-10       Impact factor: 6.577

4.  The effect of glibenclamide on insulin secretion at normal glucose concentrations.

Authors:  Axel Riefflin; Usha Ayyagari; Susan E Manley; Rury R Holman; Jonathan C Levy
Journal:  Diabetologia       Date:  2014-10-09       Impact factor: 10.122

5.  Sulphonylurea therapy doubles B-cell response to glucose in type 2 diabetic patients.

Authors:  J P Hosker; M A Burnett; E G Davies; E A Harris; R C Turner
Journal:  Diabetologia       Date:  1985-11       Impact factor: 10.122

6.  The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study.

Authors:  Denise E Bonds; Michael E Miller; Richard M Bergenstal; John B Buse; Robert P Byington; Jeff A Cutler; R James Dudl; Faramarz Ismail-Beigi; Angela R Kimel; Byron Hoogwerf; Karen R Horowitz; Peter J Savage; Elizabeth R Seaquist; Debra L Simmons; William I Sivitz; Joann M Speril-Hillen; Mary Ellen Sweeney
Journal:  BMJ       Date:  2010-01-08
  6 in total
  1 in total

1.  Within-class differences of the sulfonylureas should be accounted for. Reply to Schrijnders D, Kleefstra N and Landman GWD [letter].

Authors:  Jonathan C Levy; Axel Riefflin; Rury R Holman
Journal:  Diabetologia       Date:  2015-03-26       Impact factor: 10.122
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.